Dr. Jay Michael S. Balagtas
Claim this profileLucile Packard Children's Hospital Stanford University
Expert in Tumors
Expert in Brain Tumor
48 reported clinical trials
100 drugs studied
About Jay Michael S. Balagtas
Education:
- Obtained MD from New York Medical College in 1998.
- Completed Residency in Pediatrics at the United States Naval Medical Center San Diego in 2003.
- Undertook Fellowship in Pediatric Hematology Oncology at Stanford University in 2009.
Experience:
- Serves as Clinical Associate Professor of Pediatrics – Hematology & Oncology at Lucile Packard Children's Hospital Stanford University.
- Engaged in developing advanced VR and educational programs for personalized surgical training and congenital heart disease education.
- Authored 9 publications in the field of Pediatric Hematology-Oncology.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Jay Michael S. Balagtas is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Jay Michael S. Balagtas
Clinical Trial Related7 years of experience running clinical trials · Led 48 trials as a Principal Investigator · 22 Active Clinical TrialsTreatments Jay Michael S. Balagtas has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Methotrexate
- Vincristine Sulfate
Breakdown of trials Jay Michael S. Balagtas has run
Tumors
Brain Tumor
Leukemia
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jay Michael S. Balagtas specialize in?
Jay Michael S. Balagtas focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Jay Michael S. Balagtas currently recruiting for clinical trials?
Yes, Jay Michael S. Balagtas is currently recruiting for 18 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Jay Michael S. Balagtas has studied deeply?
Yes, Jay Michael S. Balagtas has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Jay Michael S. Balagtas?
Apply for one of the trials that Jay Michael S. Balagtas is conducting.
What is the office address of Jay Michael S. Balagtas?
The office of Jay Michael S. Balagtas is located at: Lucile Packard Children's Hospital Stanford University, Palo Alto, California 94304 United States. This is the address for their practice at the Lucile Packard Children's Hospital Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.